Question 1

What is ABVC BioPharma, Inc. Common Stock's WACC?

Accepted Answer

ABVC BioPharma, Inc. Common Stock (ABVC) has a Weighted Average Cost of Capital (WACC) of 12.01%. This is calculated using a Cost of Equity of 8.53% (via CAPM with a beta of 1.00) and a pre-tax Cost of Debt of 156.34%, with an equity weight of 97.65% in the capital structure.

Question 2

Is ABVC BioPharma, Inc. Common Stock's WACC high or low?

Accepted Answer

ABVC BioPharma, Inc. Common Stock's WACC of 12.01% is above the typical range, indicating higher perceived risk and cost of capital. WACC is used as the discount rate in DCF valuations — a lower WACC results in higher present values of future cash flows.

Question 3

How is ABVC BioPharma, Inc. Common Stock's WACC calculated?

Accepted Answer

ABVC BioPharma, Inc. Common Stock's WACC is calculated using the formula: WACC = (E/V × Re) + (D/V × Rd × (1-T)). The Cost of Equity (Re) of 8.53% is derived from the CAPM model using a beta of 1.00. The pre-tax Cost of Debt (Rd) is 156.34%. The capital structure is 97.65% equity and 2.35% debt.

ABVC BioPharma, Inc. Common Stock (ABVC) — WACC 分析

WACC 构成

解读

ABVC BioPharma, Inc. Common Stock（ABVC）WACC：12.01%

WACC计算器

ABVC BioPharma, Inc. Common Stock（ABVC） WACC 解读

ABVC 公司分析

ABVC DCF 估值

继续做同行对比